L1 Capital Pty Ltd Sells 251,844 Shares of Anteris Technologies Global (NASDAQ:AVR) Stock

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd sold 251,844 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $9.10, for a total value of $2,291,780.40. Following the completion of the transaction, the insider owned 5,187,156 shares in the company, valued at approximately $47,203,119.60. This trade represents a 4.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Tuesday, August 11th, L1 Capital Pty Ltd sold 375,815 shares of Anteris Technologies Global stock. The shares were sold at an average price of $9.30, for a total value of $3,495,079.50.
• On Thursday, August 6th, L1 Capital Pty Ltd sold 174,721 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $1,415,240.10.
• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.30, for a total transaction of $3,989,046.40.
• On Wednesday, August 5th, L1 Capital Pty Ltd sold 14,581 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.23, for a total transaction of $120,001.63.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.10, for a total transaction of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.15, for a total transaction of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.04, for a total transaction of $1,250,260.20.
• On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.20, for a total transaction of $4,580,790.60.
• On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total transaction of $1,906,771.23.
• On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total transaction of $1,688,633.79.

Anteris Technologies Global Trading Up 0.7%

NASDAQ:AVR opened at $8.93 on Friday. The firm has a market capitalization of $870.32 million, a price-to-earnings ratio of -4.58 and a beta of 1.78. The firm’s fifty day simple moving average is $9.14 and its 200 day simple moving average is $7.37. Anteris Technologies Global Corp. has a twelve month low of $3.30 and a twelve month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). The business had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative return on equity of 110.36% and a negative net margin of 4,619.27%.During the same period last year, the company posted ($0.58) earnings per share. On average, analysts predict that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current year.

Institutional Trading of Anteris Technologies Global

Several hedge funds and other institutional investors have recently bought and sold shares of AVR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Anteris Technologies Global during the 1st quarter worth approximately $32,000. Geode Capital Management LLC lifted its stake in Anteris Technologies Global by 154.3% during the second quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock worth $1,593,000 after purchasing an additional 255,088 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Anteris Technologies Global by 9,958.6% during the second quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock worth $4,049,000 after purchasing an additional 1,057,707 shares during the last quarter. Nantahala Capital Management LLC boosted its holdings in Anteris Technologies Global by 1.8% in the second quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company’s stock worth $6,419,000 after purchasing an additional 30,000 shares during the period. Finally, Vanguard Group Inc. boosted its holdings in Anteris Technologies Global by 85.1% in the third quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock worth $3,355,000 after purchasing an additional 342,711 shares during the period.

Analyst Upgrades and Downgrades

Several analysts have issued reports on AVR shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Barclays upped their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Four research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $16.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.